✦ LIBER ✦

243 Spanish lung cancer group randomized trial of preoperative chemotherapy (cisplatin either 50 mg/m2 or 100 mg/m2) in stage IIIA (N2) non-small cell lung cancer (NSCLC)

✍ Scribed by Felip, E.; Moreno, I.; Canela, M.; Alberola, V.; Gómez-Codina, J.; González-Larriba, J.L.; Antón, A.; López-Cabrerizo, M.P.; Maestre, J.; Rosell, R.

Book ID: 122521652
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 143 KB
Volume: 18
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(97)89627-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised trial comparing chemotherap

A randomised trial comparing chemotherapy regimens with cisplatin (50 mg/m2) versus moderate doses of cisplatin and carboplatin in stage iv non-small cell lung cancer

✍ Sculier, J.P; Lafitte, J.J; Thiriaux, J; Alexopoulos, C.G; Baumöhl, J; Koumakis, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Consecutive phase II trials of docetaxel

Consecutive phase II trials of docetaxel (taxotere®) 100 MG/M2 and 75 MG/M2 with prednisone in patients with stage IIIB and IV non-small cell lung cancer

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 145 KB

A multicenter randomized trial of paclit

A multicenter randomized trial of paclitaxel (175 mg/m2) plus carboplatin (6AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6AUC) in advanced non-small cell lung cancer (NSCLC)

✍ P.A. Kosmidis; N. Mylonakis; D. Skarlos; E. Samantas; M.A. Demopoulos; C. Papadi 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Preoperative High-Dose Cisplatin Versus

Preoperative High-Dose Cisplatin Versus Moderate- Dose Cisplatin Combined with Ifosfamide and Mitomycin in Stage IIIA (N2) Non–Small-Cell Lung Cancer: Results of a Randomized Multicenter Trial

✍ Enriqueta Felip; Rafael Rosell; Vicente Alberola; José Gómez-Codina; José Maestr 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 446 KB

Integrated analysis for two randomized p

Integrated analysis for two randomized phase III studies comparing Taxotere at 75 mg/m2 and 100 mg/m2 to control regimens in non-small cell lung cancer (NSCLC) patients previously treated with a platinum-based chemotherapy

✍ Kim, Y.P; Koch, G; Shepherd, F.A; Fossella, F; Hammershaimb, L; Gamza, F; Rodger 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Preliminary results of a randomized stud

Preliminary results of a randomized study comparing the efficacy of 2 doses of docetaxel 100 mg/m2/3 weeks vs 75 mg/m2/3 weeks in treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of a previous cis-platin based chemotherapy

✍ Quoix, E; Lebeau, B; Jacoulet, P; Ducolonné, A; Moro, D; Milleron, B; Lemarié, E 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB